Literature DB >> 23404911

Development of metabolic syndrome components in adults with a healthy obese phenotype: a 3-year follow-up.

C den Engelsen1, K J Gorter, P L Salomé, G E Rutten.   

Abstract

OBJECTIVE: There is a lack of data on the progression from a healthy obese phenotype toward an unhealthy obese phenotype and the development of metabolic syndrome (MetS). Our aim was to assess the development of MetS 3 years after screening in centrally obese individuals with a healthy obese phenotype and to evaluate the usefulness of repeated screening. DESIGN AND METHODS: Eighty-eight individuals (mean age 47 years, 88% female) with central obesity as their only MetS component (ATP III criteria) at baseline screening were re-evaluated for MetS status after 3 years.
RESULTS: At follow-up, the cardiometabolic risk profile in centrally obese individuals with a healthy phenotype showed a tendency toward deterioration. Thirty-two percent developed at least one additional MetS component, 7% had developed MetS. Nobody had developed type 2 diabetes. An increased triglyceride level (n = 16) and an increased blood pressure (n = 18) were the components most often present at follow-up. The people developing additional MetS components had a lower education level compared with the group that preserved the healthy centrally obese phenotype (80 vs. 71% lower educated, P = 0.35). They also had slightly worse baseline levels of the risk factors.
CONCLUSION: The number of centrally obese individuals developing an unhealthy phenotype in this relatively short follow-up period emphasizes the need for a regular surveillance of cardiometabolic parameters in centrally obese individuals. However, it is questionable whether a repeated screening for type 2 diabetes every 3 years, as recommended by the American Diabetes Association, in this category of patients is appropriate.
Copyright © 2012 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404911     DOI: 10.1002/oby.20049

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  10 in total

1.  Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.

Authors:  G C Kabat; W Y-Y Wu; J W Bea; C Chen; L Qi; M L Stefanick; R T Chlebowski; D S Lane; J Wactawski-Wende; S Wassertheil-Smoller; T E Rohan
Journal:  Int J Obes (Lond)       Date:  2016-10-17       Impact factor: 5.095

2.  Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study.

Authors:  R Eshtiaghi; S Keihani; F Hosseinpanah; M Barzin; F Azizi
Journal:  Int J Obes (Lond)       Date:  2014-10-07       Impact factor: 5.095

3.  Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.

Authors:  Camille Lassale; Ioanna Tzoulaki; Karel G M Moons; Michael Sweeting; Jolanda Boer; Laura Johnson; José María Huerta; Claudia Agnoli; Heinz Freisling; Elisabete Weiderpass; Patrik Wennberg; Daphne L van der A; Larraitz Arriola; Vassiliki Benetou; Heiner Boeing; Fabrice Bonnet; Sandra M Colorado-Yohar; Gunnar Engström; Anne K Eriksen; Pietro Ferrari; Sara Grioni; Matthias Johansson; Rudolf Kaaks; Michail Katsoulis; Verena Katzke; Timothy J Key; Giuseppe Matullo; Olle Melander; Elena Molina-Portillo; Concepción Moreno-Iribas; Margareta Norberg; Kim Overvad; Salvatore Panico; J Ramón Quirós; Calogero Saieva; Guri Skeie; Annika Steffen; Magdalena Stepien; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Yvonne T van der Schouw; W M Monique Verschuren; Claudia Langenberg; Emanuele Di Angelantonio; Elio Riboli; Nicholas J Wareham; John Danesh; Adam S Butterworth
Journal:  Eur Heart J       Date:  2018-02-01       Impact factor: 29.983

4.  The risk of heart failure and cardiometabolic complications in obesity may be masked by an apparent healthy status of normal blood glucose.

Authors:  Shuchita Tiwari; Manish Mishra; Ashok Jadhav; Courtney Gerger; Paul Lee; Lynn Weber; Joseph Fomusi Ndisang
Journal:  Oxid Med Cell Longev       Date:  2013-12-14       Impact factor: 6.543

5.  Cardiovascular disease: the other face of diabetes.

Authors:  G Vlasakakis; O Della Pasqua
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-10-23

6.  Body size trajectories and cardio-metabolic resilience to obesity.

Authors:  W Johnson
Journal:  Nutr Bull       Date:  2018-10-15

7.  Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study.

Authors:  Qian Feng; Liang-Jie Tang; Ding-Hai Luo; Ying Wang; Nan Wu; Hao Chen; Meng-Xia Chen; Lei Jiang; Rong Jin
Journal:  Cancer Manag Res       Date:  2021-11-24       Impact factor: 3.989

8.  Comparison of perceptions of obesity among adults with central obesity with and without additional cardiometabolic risk factors and among those who were formally obese, 3 years after screening for central obesity.

Authors:  Corine den Engelsen; Rimke C Vos; Mieke Rijken; Guy E H M Rutten
Journal:  BMC Public Health       Date:  2015-12-07       Impact factor: 3.295

9.  Cereal Crops Are not Created Equal: Wheat Consumption Associated with Obesity Prevalence Globally and Regionally.

Authors:  Wenpeng You; Maciej Henneberg
Journal:  AIMS Public Health       Date:  2016-05-20

Review 10.  Obesity-Related Metabolic Dysfunction in Dairy Cows and Horses: Comparison to Human Metabolic Syndrome.

Authors:  Zsofia Daradics; Cristian M Crecan; Mirela A Rus; Iancu A Morar; Mircea V Mircean; Adriana Florinela Cătoi; Andra Diana Cecan; Cornel Cătoi
Journal:  Life (Basel)       Date:  2021-12-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.